{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T04:59:01Z","timestamp":1768280341192,"version":"3.49.0"},"reference-count":54,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,13]],"date-time":"2023-12-13T00:00:00Z","timestamp":1702425600000},"content-version":"vor","delay-in-days":2872,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of nutrition, health and aging"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1007\/s12603-015-0576-y","type":"journal-article","created":{"date-parts":[[2015,8,28]],"date-time":"2015-08-28T11:48:26Z","timestamp":1440762506000},"page":"155-160","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Homocysteine and mild cognitive impairment: Are these the tools for early intervention in the dementia spectrum?"],"prefix":"10.1016","volume":"20","author":[{"given":"Zarrin","family":"Ansari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1007\/s12603-015-0576-y_bib1","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1365-2796.2004.01380.x","article-title":"Mild cognitive impairment\u2013beyond controversies, towards a consensus: Report of the International Working Group on Mild Cognitive Impairment Petersen","volume":"256","author":"Winblad","year":"2004","journal-title":"Journal of Internal Medicine"},{"key":"10.1007\/s12603-015-0576-y_bib2","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1192\/apt.5.4.279","article-title":"Age-associated memory impairment and related disorders","volume":"5","author":"O'Brien","year":"1999","journal-title":"Adv in Psy Treatment"},{"key":"10.1007\/s12603-015-0576-y_bib3","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1017\/S1041610294001626","article-title":"Aging-associated cognitive decline. Working Party of the International Psychogeriatric Association in collaboration with the World Health Organization","volume":"6","author":"Levy","year":"1994","journal-title":"Int Psychogeriatr"},{"key":"10.1007\/s12603-015-0576-y_bib4","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1212\/01.wnl.0000249117.23318.e1","article-title":"Mild cognitive impairment. Long-term course of four clinical subtypes","volume":"67","author":"Busse","year":"2006","journal-title":"Neurology"},{"key":"10.1007\/s12603-015-0576-y_bib5","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1159\/000272424","article-title":"Incidence of Mild Cognitive Impairment: A Systematic Review","volume":"29","author":"Luck","year":"2010","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.1007\/s12603-015-0576-y_bib6","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jalz.2011.01.002","article-title":"Mild Cognitive Impairment: Disparity of incidence and prevalence estimates","volume":"8","author":"Warda","year":"2012","journal-title":"Alzheimer's & Dementia"},{"key":"10.1007\/s12603-015-0576-y_bib7","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1001\/archneur.56.3.303","article-title":"Mild Cognitive Impairment. Clinical Characteristics and Outcome","volume":"56","author":"Petersen Ronald","year":"1999","journal-title":"Arch Neurol"},{"issue":"S1","key":"10.1007\/s12603-015-0576-y_bib8","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1017\/S1041610297004717","article-title":"Aging, Memory and Mild Cognitive Impairment","volume":"9","author":"Petersen Ronald","year":"1997","journal-title":"International Psychogeriatrics"},{"key":"10.1007\/s12603-015-0576-y_bib9","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1192\/bjp.bp.105.014779","article-title":"Progression of mild cognitive impairment to dementia: A challenge to current thinking","volume":"189","author":"Busse","year":"2006","journal-title":"BJP"},{"key":"10.1007\/s12603-015-0576-y_bib10","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1212\/WNL.59.2.198","article-title":"Natural history of mild cognitive Impairment in older persons","volume":"59","author":"Bennett","year":"2002","journal-title":"Neurology"},{"key":"10.1007\/s12603-015-0576-y_bib11","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S0140-6736(96)08256-6","article-title":"Progression to dementia in patients with isolated memory loss","volume":"349","author":"Bowen","year":"1997","journal-title":"Lancet"},{"issue":"2","key":"10.1007\/s12603-015-0576-y_bib12","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/ana.10069","article-title":"Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment","volume":"51","author":"DeKosky","year":"2002","journal-title":"Ann Neurol"},{"issue":"10","key":"10.1007\/s12603-015-0576-y_bib13","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1212\/01.WNL.0000144281.38555.E3","article-title":"Italian Longitudinal Study on Aging Working Group. Vascular risk factors, incidence of MCI, and rates of progression to dementia","volume":"23&63","author":"Solfrizzi","year":"2004","journal-title":"Neurology"},{"key":"10.1007\/s12603-015-0576-y_bib14","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1212\/01.WNL.0000144279.21502.B7","article-title":"Impact of APOE in mild cognitive impairment","volume":"63","author":"Farlow","year":"2004","journal-title":"Neurology"},{"key":"10.1007\/s12603-015-0576-y_bib15","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1146\/annurev-neuro-061010-113613","article-title":"Amyloid Precursor Protein Processing and Alzheimer's Disease","volume":"34","author":"O'Brien Richard","year":"2011","journal-title":"Annu Rev Neurosci"},{"issue":"7","key":"10.1007\/s12603-015-0576-y_bib16","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1212\/WNL.0000000000000692","article-title":"Multiple or mixed cerebral microbleeds and dementia in patients with vascular risk factors","volume":"83","author":"Miwa","year":"2014","journal-title":"Neurology"},{"issue":"2","key":"10.1007\/s12603-015-0576-y_bib17","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1463-1326.2004.00376.x","article-title":"Homocysteine concentrations in patients with diabetes mellitus\u2013relationship to microvascular and macrovascular disease","volume":"7","author":"Elias Alan","year":"2005","journal-title":"Diabetes, Obesity and Metabolism"},{"issue":"12","key":"10.1007\/s12603-015-0576-y_bib18","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1001\/archneur.64.12.1734","article-title":"Hypertension and the Risk of Mild Cognitive Impairment","volume":"64","author":"Reitz","year":"2007","journal-title":"Arch Neurol"},{"key":"10.1007\/s12603-015-0576-y_bib19","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.1001\/jama.292.23.2901","article-title":"Emerging Concepts and Therapeutic Implications","volume":"292","author":"Langa Kenneth","year":"2004","journal-title":"JAMA"},{"key":"10.1007\/s12603-015-0576-y_bib20","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jns.2009.02.314","article-title":"Cerebral white matter lesions in patients with dementia\u2013from MCI to severe dementia","volume":"283","author":"Targosz-Gajniak","year":"2009","journal-title":"J Neurol Sciences"},{"key":"10.1007\/s12603-015-0576-y_bib21","first-page":"1274","article-title":"Clinical correlates of white-matter findings on cranial magnetic resonance imaging of 3,301 elderly people","volume":"27","author":"Longstreth","year":"1996","journal-title":"The Cardiovascular Health Study Collaborative Research Group. Stroke"},{"issue":"7","key":"10.1007\/s12603-015-0576-y_bib22","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1212\/WNL.44.7.1246","article-title":"Cerebral white-matter lesions, vascular risk factors, and cognitive function in a population-based study: The Rotterdam Study","volume":"44","author":"Breteler","year":"1994","journal-title":"Neurology"},{"issue":"22","key":"10.1007\/s12603-015-0576-y_bib23","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1001\/jama.1993.03510220049033","article-title":"Vitamin status and intake as primary determinants of homocysteinemia in an elderly population","volume":"270","author":"Selhub","year":"1993","journal-title":"JAMA"},{"issue":"4","key":"10.1007\/s12603-015-0576-y_bib24","doi-asserted-by":"crossref","first-page":"281","DOI":"10.3988\/jcn.2014.10.4.281","article-title":"Hyperhomocysteinemia and Neurologic Disorders: A Review","volume":"10","author":"Ramin","year":"2014","journal-title":"J Clin Neurol"},{"key":"10.1007\/s12603-015-0576-y_bib25","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1161\/01.STR.0000069017.78624.37","article-title":"Homocysteine and Risk of Recurrent Stroke","volume":"34","author":"Boysen","year":"2003","journal-title":"Stroke"},{"key":"10.1007\/s12603-015-0576-y_bib26","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1136\/bmj.325.7374.1202","article-title":"Homocysteine and cardiovascular disease: Evidence on causality from a metaanalysis","volume":"325","author":"Wald David","year":"2002","journal-title":"BMJ"},{"key":"10.1007\/s12603-015-0576-y_bib27","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1532-5415.2011.03774.x","article-title":"Memory and Ageing Study Team. Risk profiles of mild cognitive impairment: The Sydney memory and ageing study","volume":"60","author":"Sachdev","year":"2012","journal-title":"J Am Geriatr Soc"},{"key":"10.1007\/s12603-015-0576-y_bib28","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1159\/000087297","article-title":"The relation between homocysteine levels and development of Alzheimer's disease in mild cognitive impairment patients","volume":"20","author":"Annerbo","year":"2005","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.1007\/s12603-015-0576-y_bib29","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1056\/NEJMoa011613","article-title":"Plasma Homocysteine as a Risk Factor for Dementia And Alzheimer's Disease","volume":"346","author":"Sheshadri","year":"2002","journal-title":"NEJM"},{"key":"10.1007\/s12603-015-0576-y_bib30","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1093\/jn\/137.9.2093","article-title":"Plasma homocysteine Is Associated with the Risk of Mild Cognitive Impairment in an Elderly Korean Population","volume":"137","author":"Jihye","year":"2007","journal-title":"J Nutr"},{"key":"10.1007\/s12603-015-0576-y_bib31","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1159\/000051275","article-title":"Homocysteine and Cognitive Decline in Healthy Elderly","volume":"12","author":"McCaddon","year":"2001","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.1007\/s12603-015-0576-y_bib32","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1093\/ajcn\/82.3.627","article-title":"III. High homocysteine and low vitamins predict cognitive decline in aging men: The Veterans Affairs Normative Aging Study","volume":"82","author":"Tucker Katherine","year":"2005","journal-title":"Am J Clin Nutr"},{"key":"10.1007\/s12603-015-0576-y_bib33","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1053\/euhj.1999.1914","article-title":"Homocysteine and atherothrombosis\u2013mechanisms for injury","volume":"21","author":"Thambyrajah","year":"2000","journal-title":"Eur Heart J."},{"key":"10.1007\/s12603-015-0576-y_bib34","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1023\/A:1005377310872","article-title":"Putative mechanisms for vascular damage by homocysteine","volume":"20","author":"Bellamy","year":"1997","journal-title":"J Inher Metab. Dis"},{"key":"10.1007\/s12603-015-0576-y_bib35","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jns.2004.09.006","article-title":"cerebrovascular disease and brain atrophy","volume":"226","author":"Sachdev","year":"2004","journal-title":"J of Neurological Sciences"},{"key":"10.1007\/s12603-015-0576-y_bib36","doi-asserted-by":"crossref","first-page":"5923","DOI":"10.1073\/pnas.94.11.5923","article-title":"Neurotoxicity associated with dual actions of homocysteine at the N-methyl-D-aspartate receptor","volume":"94","author":"Lipton","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1007\/s12603-015-0576-y_bib37","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S0197-0186(03)00038-X","article-title":"Role of group I metabotropic glutamate receptors and NMDA receptors in homocysteine-evoked acute neurodegeneration of cultured cerebellar granule neurones","volume":"43","author":"Zieminska","year":"2003","journal-title":"Neurochem. Int"},{"key":"10.1007\/s12603-015-0576-y_bib38","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.1016\/j.febslet.2006.04.088","article-title":"Mechanisms of homocysteine neurotoxicity in neurodegenerative diseases with special reference to dementia","volume":"580","author":"Obeid","year":"2006","journal-title":"FEBS Letters"},{"key":"10.1007\/s12603-015-0576-y_bib39","doi-asserted-by":"crossref","first-page":"4725","DOI":"10.1073\/pnas.92.11.4725","article-title":"Apolipoprotein E and Alzheimer's disease","volume":"92","author":"Strittmatter Warren","year":"1995","journal-title":"Proc Natl. Acad. Sci. USA."},{"key":"10.1007\/s12603-015-0576-y_bib40","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.neulet.2007.10.021","article-title":"Homocysteine and Cognitive Performance: Modification by the ApoE genotype","volume":"430","author":"Elias Merrill","year":"2008","journal-title":"Neurosciences Letters"},{"key":"10.1007\/s12603-015-0576-y_bib41","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1212\/01.wnl.0000183063.99107.5c","article-title":"Association of homocysteine with plasma \u00df-amyloid protein in aging and neurodegenerative disease","volume":"65","author":"Irizarry","year":"2005","journal-title":"Neurology"},{"issue":"6","key":"10.1007\/s12603-015-0576-y_bib42","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1002\/ana.24145","article-title":"Homocysteine exacerbates \u00df-amyloid pathology, tau pathology, and cognitive deficit in a mouse model of Alzheimer's disease with plaques and tangles","volume":"75","author":"Li","year":"2014","journal-title":"Ann Neurol"},{"key":"10.1007\/s12603-015-0576-y_bib43","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/j.neurobiolaging.2014.01.013","article-title":"Association of homocysteine with hippocampal volume independent of cerebral amyloid and vascular burden","volume":"35","author":"Choe","year":"2014","journal-title":"Neurobiology of Aging"},{"issue":"9","key":"10.1007\/s12603-015-0576-y_bib44","doi-asserted-by":"crossref","first-page":"e12244","DOI":"10.1371\/journal.pone.0012244","article-title":"Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial","volume":"5","author":"A David","year":"2010","journal-title":"PLoS One"},{"issue":"23","key":"10.1007\/s12603-015-0576-y_bib45","doi-asserted-by":"crossref","first-page":"9523","DOI":"10.1073\/pnas.1301816110","article-title":"Preventing Alzheimer's disease-related gray matter atrophy by B-vitamin treatment","volume":"110","author":"Douaud","year":"2013","journal-title":"roc Natl Acad Sci U S A"},{"key":"10.1007\/s12603-015-0576-y_bib46","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1002\/gps.2758","article-title":"Cognitive and clinical outcomes of homocysteine-lowering B-vitamin treatment in mild cognitive impairment: A randomized controlled trial","volume":"27","author":"De Jager Celeste","year":"2012","journal-title":"Int J of Geriatric Psychiatry"},{"key":"10.1007\/s12603-015-0576-y_bib47","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s12603-012-0051-y","article-title":"Conversion from mild cognitive impairment to dementia: Influence of folic acid and vitamin B12 use in the VITA cohort","volume":"16","author":"Blasko","year":"2012","journal-title":"J Nutrition, Health and Aging"},{"key":"10.1007\/s12603-015-0576-y_bib48","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/S0140-6736(07)60109-3","article-title":"Effect of 3-years folic acid supplementation on cognitive function in older adults in the FACIT trial: A randomised, double-blind, controlled trial","volume":"369","author":"Durga","year":"2007","journal-title":"Lancet"},{"key":"10.1007\/s12603-015-0576-y_bib49","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1159\/000071002","article-title":"Vitamin B12-B6-Folate Treatment Improves Blood-Brain Barrier Function in Patients with Hyperhomocysteinemia and Mild Cognitive Impairment","volume":"16","author":"Lehmann","year":"2003","journal-title":"Dement Geriatr Cogn Discord"},{"key":"10.1007\/s12603-015-0576-y_bib50","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/00002093-199100520-00006","article-title":"Pathogenetic basis of vascular dementia","volume":"5","author":"Wallin","year":"1991","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"10.1007\/s12603-015-0576-y_bib51","doi-asserted-by":"crossref","first-page":"657","DOI":"10.3945\/ajcn.113.076349","article-title":"Effects of homocysteine-lowering with B vitamins on cognitive aging: Meta-analysis of 11 trials with cognitive data on 22,000 individuals","volume":"100","author":"Clarke","year":"2014","journal-title":"Am J Clin Nutr"},{"issue":"8","key":"10.1007\/s12603-015-0576-y_bib52","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1161\/STROKEAHA.113.001886","article-title":"Effect of B vitamins and lowering homocysteine on cognitive impairment in patients with previous stroke or transient ischemic attack: A pre-specified secondary analysis of a randomized, placebo-controlled trial and meta-analysis","volume":"44","author":"Hankey","year":"2013","journal-title":"Stroke"},{"issue":"15","key":"10.1007\/s12603-015-0576-y_bib53","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1001\/jama.300.15.1774","article-title":"High-Dose B Vitamin Supplementation and Cognitive Decline in Alzheimer's Disease: A Randomized Controlled Trial","volume":"300","author":"Aisen Paul","year":"2008","journal-title":"JAMA"},{"key":"10.1007\/s12603-015-0576-y_bib54","doi-asserted-by":"crossref","unstructured":"Van der Zwaluw NL, Dhonukshe-Rutten RA, Van Wijngaarden JP, Brouwer-Brolsma EM, Van de Rest O, In' t Veld PH, Enneman AW, Van Dijk SC, Ham AC, Swart KM, Van der Velde N, Van Schoor NM, Van der Cammen TJ, Uitterlinden AG, Lips P, Kessels RP, De Groot LC. Results of 2-year vitamin B treatment on cognitive performance: Secondary data from an RCT. Neurology. 2014 Nov 12. pii: 10.1212\/WNL.0000000000001050.","DOI":"10.1212\/WNL.0000000000001050"}],"container-title":["The Journal of nutrition, health and aging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12603-015-0576-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12603-015-0576-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1279770723013489?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1279770723013489?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12603-015-0576-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T12:55:25Z","timestamp":1761137725000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1279770723013489"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":54,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["S1279770723013489"],"URL":"https:\/\/doi.org\/10.1007\/s12603-015-0576-y","relation":{},"ISSN":["1279-7707"],"issn-type":[{"value":"1279-7707","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Homocysteine and mild cognitive impairment: Are these the tools for early intervention in the dementia spectrum?","name":"articletitle","label":"Article Title"},{"value":"The Journal of nutrition, health and aging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s12603-015-0576-y","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 SERDI Publisher.","name":"copyright","label":"Copyright"}]}}